Clinical Specialty Portfolio

GASTROENTEROLOGY & ACID-PEPTIC CARE

3 Formulations

Proton pump inhibitors and prokinetic formulations for sustained acid suppression and reflux relief.

Clinical Focus

GERD, Non-Ulcer Dyspepsia, Erosive Esophagitis & Gastric Ulcers

Key Molecules:Rabeprazole SodiumPantoprazole SodiumDomperidone SR

Marketed Formulations in Gastroenterology & Acid-Peptic Care

Each product is formulated in compliance with strict Indian Pharmacopoeia assay standards.

Hard Gelatin Capsules

Schedule H Rx

Rabeprazole Sodium & Domperidone (SR) Capsules

Dual-action gastroprotective capsule combining fast-acting proton pump inhibitor with sustained-release prokinetic.

Composition: Rabeprazole Sodium IP (enteric coated) 20 mg, Domperidone IP (sustained release) 30 mg, Approved colours in capsule shell

Pack: Strip of 10 Capsules

Gastro-resistant Tablets

Schedule H Rx

Pantoprazole Gastro-resistant Tablets IP

Dependable enteric-coated proton pump inhibitor tablet for gastric acid suppression and mucosal healing.

Composition: Pantoprazole Sodium IP equivalent to Pantoprazole 40 mg, Colour: Ferric Oxide Yellow & Titanium Dioxide

Pack: Strip of 10 Tablets

Lyophilized Injection (IV)

Schedule H Rx

Pantoprazole for Injection IP 40 mg

Intravenous lyophilized proton pump inhibitor for immediate acid suppression in acute hospital and clinical settings.

Composition: Sterile Pantoprazole Sodium IP equivalent to Pantoprazole 40 mg, Lyophilized freeze-dried powder for reconstitution

Pack: Single Dose Vial (with Sterile Water for Injection)